Search bioRxiv⌕ Search

Biology subjects

Lalgudi, C. K.

Publications and source records attributed to Lalgudi, C. K..

2 recordsLinked to original sources

PhenoMapR: scalable mapping of sample phenotypes to single-cell, spatial, and bulk transcriptomics data

Single-cell and spatial transcriptomic studies often lack sufficient sample size to compute robust statistical associations between a sample-level phenotype and cell types or spatial locations. In contrast, lower resolution methods such as bulk gene expression profiling have been applied at scale in large, annotated datasets, providing reliable signatures for phenotype associations. We introduce PhenoMapR, a semi-supervised method designed to integrate the phenotypic rigor of large-scale bulk expression studies with the cellular and spatial granularity of single-cell and spatial transcriptomics. PhenoMapR achieves this by deriving and mapping bulk gene expression signatures onto cells and spatial locations in a computationally efficient and scalable manner. The framework is broadly applicable across biological contexts, supporting the mapping of binary, continuous, and survival phenotypes derived from bulk expression studies across transcriptomic data modalities. This enables the identification of biologically-relevant cellular populations and spatial niches for experimental validation and therapeutic intervention.

bioinformatics↗

PRECOG update: An augmented resource of clinical outcome associations with gene expression for pediatric and immunotherapy cohorts

Gene expression can be used to define prognostic and predictive biomarkers across cancers and treatment modalities. PRECOG (https://precog.stanford.edu) is a compendium of datasets with gene expression and clinical outcomes that facilitates visualization of associations between genomic profiles and patient survival. Here, we augment the existing PRECOG with new datasets in previously poorly represented adult cancer types, as well as adding annotated pediatric and immunotherapy treated cohorts. Pediatric PRECOG comprises [~]4,000 patients across 12 cancers; while the immunotherapy cohort (ICI PRECOG) contains [~]4,500 patients across 20 cancer subtypes from 80 distinct datasets across 52 studies. We compute and visualize associations of gene expression with survival outcomes using Cox regression for time-to-event, or logistic regression for responder vs non-responder, across all datasets. We also estimate cell type fractions in samples via computational deconvolution using CIBERSORTx, to identify survival associations at the level of cell types. All expression data, clinical annotations, and gene and cell type survival z-scores and meta z-scores for adult, pediatric, and ICI PRECOG, are available for interactive analysis and download, along with Kaplan-Meier and boxplot visualizations. This updated resource will provide new insights into biomarkers for specific therapies, populations, and cancer types. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=80 SRC="FIGDIR/small/671849v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@13446bdorg.highwire.dtl.DTLVardef@11025fcorg.highwire.dtl.DTLVardef@12e017corg.highwire.dtl.DTLVardef@1637dba_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioinformatics↗